Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
Quantitative Imaging Workshop XX
Digestive Disease Week 2024
2024 NCCN Annual Conference
European Association of Urology Congress 2024
AACR Annual Meeting 2024
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Error loading Partial View script (file: ~/Views/MacroPartials/TAP List Meeting Articles.cshtml)
Advertisement
Advertisement
May
21
Today In Oncology
Metformin May Help Reduce the Risk of Developing Myeloproliferative Neoplasms
Outcomes for Cancer Drugs Initially FDA-Approved With Immature Overall Survival Data
Advanced Gastric or Gastroesophageal Junction Cancer Addition of Relatlimab to Immunochemotherapy
Linvoseltamab Achieves High Response Rates in Relapsed or Refractory Myeloma
Improving AML Outcomes Testing for MRD Prior to Bone Marrow Transplant
View More
Advertisement